Karpus Investment Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-603,425
Closed -$6.37M 252
2026
Q1
$6.37M Sell
603,425
-10,000
-2% -$105K 0.2% 115
2025
Q4
$6.42M Sell
613,425
-3,350
-0.5% -$34.9K 0.2% 114
2025
Q3
$6.38M Hold
616,775
0.2% 97
2025
Q2
$6.33M Buy
616,775
+9,850
+2% +$100K 0.2% 107
2025
Q1
$6.12M Buy
+606,925
New +$6.1M 0.2% 114

Other funds holding TDAC

Karpus Investment Management's TDAC Position: Q2 2026 in Review

Karpus Investment Management sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 603,425 shares — an estimated $6.37M sold.

Karpus Investment Management first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $6.42M in Q4 2025. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Karpus Investment Management reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Karpus Investment Management sold 603,425 Translational Development Acquisition Corp shares in Q2 2026, an estimated $6.37M.
  • Karpus Investment Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • Karpus Investment Management's Translational Development Acquisition Corp position peaked at $6.42M in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Karpus Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.